Lack of independent prognostic and predictive value of centromere 17 copy number changes in breast cancer patients with known HER2 and TOP2A status
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Lack of independent prognostic and predictive value of centromere 17 copy number changes in breast cancer patients with known HER2
and TOP2A
status
Authors
Keywords
-
Journal
Molecular Oncology
Volume 6, Issue 1, Pages 88-97
Publisher
Wiley
Online
2011-12-02
DOI
10.1016/j.molonc.2011.11.006
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- HER2 and TOP2A as predictive markers for anthracycline-containing chemotherapy regimens as adjuvant treatment of breast cancer: a meta-analysis of individual patient data
- (2011) Angelo Di Leo et al. LANCET ONCOLOGY
- Chromosome 17 Polysomy without Human Epidermal Growth Factor Receptor 2 Amplification Does Not Predict Response to Lapatinib Plus Paclitaxel Compared with Paclitaxel in Metastatic Breast Cancer
- (2010) L. Downey et al. CLINICAL CANCER RESEARCH
- Targeting chromosomal instability and tumour heterogeneity in HER2-positive breast cancer
- (2010) Rebecca A. Burrell et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- HER2and Chromosome 17 Effect on Patient Outcome in the N9831 Adjuvant Trastuzumab Trial
- (2010) Edith A. Perez et al. JOURNAL OF CLINICAL ONCOLOGY
- Alteration of Topoisomerase II–Alpha Gene in Human Breast Cancer: Association With Responsiveness to Anthracycline-Based Chemotherapy
- (2010) Michael F. Press et al. JOURNAL OF CLINICAL ONCOLOGY
- Predictive markers of anthracycline benefit: a prospectively planned analysis of the UK National Epirubicin Adjuvant Trial (NEAT/BR9601)
- (2010) John MS Bartlett et al. LANCET ONCOLOGY
- Absence of chromosome 17 polysomy in breast cancer: analysis by CEP17 chromogenic in situ hybridization and multiplex ligation-dependent probe amplification
- (2009) Cathy B. Moelans et al. BREAST CANCER RESEARCH AND TREATMENT
- Disease-Free Survival According to Degree ofHER2Amplification for Patients Treated With Adjuvant Chemotherapy With or Without 1 Year of Trastuzumab: The HERA Trial
- (2009) Mitch Dowsett et al. JOURNAL OF CLINICAL ONCOLOGY
- Be precise! The need to consider the mechanisms forCEP17copy number changes in breast cancer
- (2009) Giuseppe Viale JOURNAL OF PATHOLOGY
- Does chromosome 17 centromere copy number predict polysomy in breast cancer? A fluorescencein situhybridization and microarray-based CGH analysis
- (2009) Caterina Marchiò et al. JOURNAL OF PATHOLOGY
- Topoisomerase II Alpha and Responsiveness of Breast Cancer to Adjuvant Chemotherapy
- (2009) F. P. O'Malley et al. JNCI-Journal of the National Cancer Institute
- Breast cancer and aneusomy 17: implications for carcinogenesis and therapeutic response
- (2009) Monica M Reinholz et al. LANCET ONCOLOGY
- Clinical validation of an array CGH test for HER2 status in breast cancer reveals that polysomy 17 is a rare event
- (2009) I-Tien Yeh et al. MODERN PATHOLOGY
- The value ofTOP2Agene copy number variation as a biomarker in breast cancer: Update of DBCG trial 89D
- (2008) Kirsten Vang Nielsen et al. ACTA ONCOLOGICA
- Determination ofHER2Amplification by In Situ Hybridization
- (2008) John M.S. Bartlett et al. AMERICAN JOURNAL OF CLINICAL PATHOLOGY
- HER-2 Gene Amplification, HER-2 and Epidermal Growth Factor Receptor mRNA and Protein Expression, and Lapatinib Efficacy in Women with Metastatic Breast Cancer
- (2008) M. F. Press et al. CLINICAL CANCER RESEARCH
- Type 1 Receptor Tyrosine Kinase Profiles Identify Patients With Enhanced Benefit From Anthracyclines in the BR9601 Adjuvant Breast Cancer Chemotherapy Trial
- (2008) John M.S. Bartlett et al. JOURNAL OF CLINICAL ONCOLOGY
- Polysomy 17 in Breast Cancer: Clinicopathologic Significance and Impact on HER-2 Testing
- (2008) Isabelle Vanden Bempt et al. JOURNAL OF CLINICAL ONCOLOGY
- The WSB1 Gene Is Involved in Pancreatic Cancer Progression
- (2008) Cendrine Archange et al. PLoS One
- HER2 Status and Efficacy of Adjuvant Anthracyclines in Early Breast Cancer: A Pooled Analysis of Randomized Trials
- (2007) Alessandra Gennari et al. JNCI-Journal of the National Cancer Institute
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now